Massivemarkets

PBLS

Parabilis Medicines, Inc. Common Stock

Nasdaq · usd

$26.77-1.48 (-5.24%)
As of 4:02:15 AM EST on Nov 19, 2026 · 15-minute delayed

Parabilis Medicines, Inc. Common Stock (PBLS) trades at $26.77 (-5.24%) as of 4:02:15 AM EST on Nov 19, 2026, +5.13% over the past month. Market cap is $3.57B, with 8.3 days to cover in short interest.

Stock performance

How Parabilis Medicines, Inc. Common Stock (PBLS) stock has performed from one day to one year, with its 52-week range.

+3.44%
+$0.96 over 1D
$28.00$28.34$28.69$29.039:30 AM11:10 AM12:50 PM2:25 PM8:00 PM$28.88
1D
+0.78%
1W
-3.98%
1M
+5.13%
YTD
-9.91%
1Y
-9.91%
52-wk range
$22.66 – $42.49

Key statistics

Today's trading snapshot for PBLS: day range, open, previous close, volume and market cap.

Day range
$27.70 – $29.26
Open
$28.22
Prev close
$28.25
Volume
602.37K
Market cap
$3.57B
Shares out
125.26M

8-K filings

Material corporate events Parabilis Medicines, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, Parabilis Medicines, Inc. (the "Company") announced its financial results and business highlights for the quarter ended September 30, 2026.

  • Lease agreementNov 5, 2026

    On October 30, 2026, Parabilis Medicines, Inc. and LS 400/500 CDP, LLC entered into a Third Amendment of Lease, which amends the Lease regarding the Company's corporate headquarters located at 30 Acorn Park Drive, Cambridge, Massachusetts. The Amendment provides for an expansion, beginning on January 1, 2028, of the leased space by a total of 33,525 square feet at 20 Acorn Park Drive, an extension of the lease term through December 31, 2037, and options for further five-year extensions.

  • Executive compensation changeSep 2, 2026

    In connection with his departure from the Company, Dr. Benzaghou will receive severance benefits pursuant to the terms of his employment agreement with the Company.

  • Executive compensation changeAug 25, 2026

    In accordance with the Company's compensation program for non-employee directors, Mr. Tendler received an equity award consisting of a stock option to purchase 20,294 shares of the Company's common stock at an exercise price of $39.36 per share. The option award will vest in thirty-six substantially equal monthly installments over three years from the date of grant... Mr. Tendler will also receive an annual retainer of $40,000 for Board service and $7,500 for Science & Technology Committee service, each to be paid quarterly in arrears.

  • Investor presentationAug 13, 2026

    On August 13, 2026, the Company updated its corporate presentation for use in meetings with investors, analysts and others from time to time and made the presentation available on the investor relation page of the Company's website at https://parabilismed.com/. A copy of the presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K.

PBLS short interest

How heavily PBLS is shorted: shares short, days to cover and average daily volume.

Days to cover
8.3
Short interest
11.05M
Avg volume
1.33M

As of · reported to FINRA twice monthly.

PBLS news

The latest news and headlines about Parabilis Medicines, Inc. Common Stock (PBLS).

Frequently asked questions

What is the Parabilis Medicines, Inc. Common Stock (PBLS) stock price today?

Parabilis Medicines, Inc. Common Stock (PBLS) is trading at $26.77 (-5.24% on the day) as of 4:02:15 AM EST on Nov 19, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Parabilis Medicines, Inc. Common Stock?

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases.

What is the short interest in PBLS?

As of Oct 30, 2026, PBLS has 11.05M shares short and 8.3 days to cover.

What exchange is PBLS listed on?

Parabilis Medicines, Inc. Common Stock (PBLS) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of PBLS with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a PBLS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.